TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15 | 0.0% | 971 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $15 | -6.2% | 971 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $16 | +6.7% | 971 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $15 | -99.9% | 971 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $13,000 | -7.1% | 971 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $14,000 | 0.0% | 971 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $14,000 | +7.7% | 971 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $13,000 | -18.8% | 971 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $16,000 | 0.0% | 971 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $16,000 | – | 971 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |